Angiodroid

Angiodroid offers all the advantages of using CO2 as contrast medium for angiographies (safety, costs, nephropatic patients) with the reliability of iodine

  • Stage $500K in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location San Lazzaro di Savena, Bologna, Italy
  • Currency EUR
  • Founded July 2013
  • Employees 10
  • Website angiodroid.com

Company Summary

Angiodroid sells globally the safest and most effective injector for peripheral interventional angiography that uses CO2 as contrast medium, avoiding the difficult catabolysm of iodine, which makes angiographies very taxing for nephropatic patients. Angiodroid overcomes the safety and reliability limit of current CO2 manual tools with a CE marked device capable of insuring a continuous control on CO2 purity, pressure and flow during injection.

Team

  • Michele Marzola
    Chairman

    Serial entrepreneur with experience in more than 22 start-ups. Previously General manager of IBM Consulting Group and Principal at Booz Allen & Hamilton. MBA at Columbia University, MS Mechanical Engineering at Bologna University

  • Sebastiano Zannoli
    Founder and Chief Executive Officer

    Serial Entrepreneur, 17 years experience in management consulting and in management of medical devices companies (Managing consultant at Consiel spa, Sales director at GS Biomedica for managing distribution of St. Jude Medical, GE Medical Systems and Cyberonics products)

  • Tomas Bilardo
    Sales Executive

    Previous experience as Marketing and Sales director at SIAS Spa and Gada Group Italy

  • Samuele Zannoli
    Founder and CTO

    Degree in physics, 18 years experience in medical software development (University of Bologna - Dept. Of Physics, SparkBio, SIAS)

Previous Investors

  • SparkBio srl
    Founder
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free